Procainamide hydrochloride
- Level
- Commodity
- Parent
- 51123100
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51123116This classification denotes a cation channel blocker and antiarrhythmic agent with the molecular formula C13H21N3O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SI4064O0LX, chemically known as benzamide, p-amino-n-(2-(diethylamino)ethyl)-, hydrochloride but more generally known as procainamide hydrochloride, which bears US NIH Compound Identifier 66068. European Medicines Agency schedules Procainamide hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04045MIG. Most nations, for tariff and trade purposes, schedule procainamide hydrochloride under HS 29242995 and SITC 51479. As of Q4 2014, PROCAINAMIDE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Procainamide hydrochloride bears US NLM identifiers UMLS ID C0699067 and NCI Concept Code C47687. SMILES: CCN(CC)CCNC(=O)C1CCC(CC1)N.CL.
Same parent
Under 51123100 · 20Activities that produce or sell this
KBLI · 8Inherited from family 51120000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.